RDIF says rivals envy Sputnik VТs potency, lobby for sanctions - News Archive - PRIME Business News Agency - All News Politics Economy Business Wire Financial Wire Oil Gas Chemical Industry Power Industry Metals Mining Pulp Paper Agro Commodities Transport Automobile Construction Real Estate Telecommunications Engineering Hi-Tech Consumer Goods Retail Calendar Our Features Interviews Opinions Press Releases

RDIF says rivals envy Sputnik VТs potency, lobby for sanctions

MOSCOW, Jan 13 (PRIME) -- Major pharmaceutical companies are lobbying for sanctions against the Russian Direct Investment Fund (RDIF) to prevent the promotion of the Sputnik V COVID-19 vaccine, which has proven to be highly effective, head of the fund Kirill Dmitriev said at a forum on Thursday.

УThe Big Pharma (companies) are actively lobbying, among other things, to impose sanctions on the RDIFЕ to prevent Sputnik from saving lives,Ф Dmitriev said.

According to Dmitriev, Western media often impede the dissemination of information about the Russian vaccine.

УPeople around the globe need to know the truth. Sputnik protects well against hospitalizations and deaths from Omicron, better than other vaccines.Ф

Dmitriev also said the fund plans to make several important announcements regarding SputnikТs high effectiveness next week.


13.01.2022 18:34
Share |
To report an error select text and press Ctrl+Enter
Central Bank Official Rate
1W 1M 1Y
EUR 61.2171 +0.2139 29 jul
USD 60.2031 -0.0167 29 jul
Stock Market Indices
1D 1W 1M 1Y
micex 2189.16 -0.32 18:51 28 jul
Stock Quotes in RUR
1D 1W 1M 1Y
gazp 196.24 -0.13 18:36 28 jul
lkoh 3847.50 0.00 18:53 28 jul
rosn 348.70 0.00 18:49 28 jul
sber 131.69 -0.61 18:36 28 jul
MICEX Ruble Trading
1D 1W 1M 1Y
EURTD 61.1000 +0.5550 14:59 28 jul
USDTD 60.8350 +0.9200 17:44 28 jul